Company intelligence
Juniper Biosciences
Developing innovative radiopharmaceutical products for the future of patient care
Pharmaceutical Manufacturing
Bedminster, US
2–10 employees
Founded 2025
3 public signals
About Juniper Biosciences
Juniper Biosciences is a radiopharmaceutical company focused on developing its pipeline of innovative products
Verified activity
Signals from Juniper Biosciences
3 published signals
Legal & Regulatory
Juniper Biosciences received Breakthrough Therapy Designation for its JBS-003 program in partnership with MSKCC, which was pioneered by Dr. Nancy Lee.
Reported by Juniper Biosciences
Legal & Regulatory
Juniper Biosciences received Breakthrough Therapy designation from the FDA for its Phase III program JBS-003 (F-MISO) in partnership with MSKCC.
Reported by Juniper Biosciences
Legal & Regulatory
Juniper Biosciences received Breakthrough Therapy designation from the FDA in partnership with MSKCC for its Phase III program.
Reported by Alex Agnoletto